2 min reading time
All Class II devices marketed in the USA must be labeled with UDI bar codes by September 24, 2016–just 19 days away. This announcement summarizes the basic steps for UDI implementation. Step 1: Make a list of all the devices requiring a UDI. A separate UDI is needed for each size and packaging configuration. For example, if you sell sterile syringes individually, ten per box and 100 per case–then you need three different UDI for each size of syringe you sell. Step 2: Apply for a block of device identifiers (DIs) from GS1 (http://www.gs1.org/) or a single labeler identification code (LIC) from HIBCC (http://www.hibcc.org/). GS1 sells blocks of DIs in quantities of 10, 100, 1000, etc.; while HIBCC sells a single LIC. GS1 blocks of DIs are generally less expensive than a single LIC, but there are also maintenance charges. Therefore, HIBCC is typically less expensive in the long run for companies. For a small company these charges are approximately $1,000 (order of magnitude estimate). Step 3: Assign DIs to each of your devices from step 1. There are 55 attributes for each DI provided in the upload to the FDA GUDID. Most UDI consultants will be able to provide a sample procedure to manage this process and a form for approving the attribute data for each new DI. You can do this yourself with an Excel spreadsheet template, but use the free FDA GUDID elements reference table as a starting point for creating your own form: Step 4: Request a GUDID account from the FDA. The FDA responds to requests in a few days and you will have full account access in about a week. The following webpage provides information for requesting access: Step 5: Create sample UDIs for each device assigned a DI. You need software to generate a bar code in the required UDI format and then the code is inserted into your label template for each lot. Serialized products need software that generates a series of serialized bar codes. You can manually review and approve each sample UDI and the final label, but you must verify that the bar code is machine readable (i.e., automatic identification and data capture (AIDC) technology). This process is required for each device before you upload the information to the GUDID. Step 6: Enter GUDID elements for each device into the FDA GUDID. This can be done manually and verified for accuracy, or it can be done automatically with a validated software system. Reed Tech (http://www.reedtech.com/products-services/life-sciences/medical-device-udi-management) offers software designed for small and mid-size medical device manufacturers to automatically upload all of the data elements. If you have 10 devices in total, this process can be implemented manually in a few weeks. If you have closer to 100 devices, you will probably need more time to complete the implementation. Prioritize your highest volume products first. Although the compliance deadline is September 24, there is a grace period of three years for existing inventory. Any inventory labeled prior to September 24, does not need to be relabeled if it is distributed within that three year period. If you have more than 100 different devices, then you may find that you need an automated system to help you generate UDI bar codes and maintain information for the FDA GUDID. UDI implementation may be your reason for upgrading to a new MRP software system or implementation of on-demand printing. Automation projects require longer to implement in order to populate the software database, validate the software and train personnel. You may need to implement UDI labeling in parallel with planning and implementation of an automated system. source: https://www.linkedin.com/groups/2070960/2070960-6178555579401793536 Marked as spam
|
Meet your next client here. Join our medical devices group community.
|
|
Private answer
Lewis Lee
Good information. Just a quick question, inventory prior 9/24, how does the custom know about it or strictly based upon honest system? Should we submit a proof of production or declaration to ship old inventory after 9/24? Thanks!
Marked as spam
|
|
Private answer
Rob Packard
To answer Lewis' question, all of the device history records must show that the product was released prior to the 9/24 deadline. Customers that don't need a UDI won't care, and customers that need a UDI have probably already required it. The FDA may check compliance, by checking one of the lots after 9/24 during an inspection. The bigger issue will be relabeling in 2019 at the end of 3 years.
Marked as spam
|
|
Private answer
Ady Banin
Thank you for great summary. Do you what's going on it parallel in Europe with the UDI? it seems there's still no final word on it....
Marked as spam
|
|
Private answer
Rob Packard
The Europeans are trying to mirror what is going on with the US so that global labeling requirements are harmonized as much as possible. The US has also recognized ISO 15223-1 for the same reasons. The big difference in Europe is that the transition period for the highest risk Class III devices have not even started yet.
Marked as spam
|
|
Private answer
Ady Banin
Thank You Robert for your reply.
What approach would you recommend to the UDI for Class III devices that are only distributed in the EU but may, in the future, be distributed to the US as well? I tried following the EC recommendations on UDIs, the IMDRF guidance doc, and could not make sense of it... My thoughts were to stick to the FDA's UDI rules, under the assumption that the EU will eventually adopt it as-is to a real global, harmonized database of medical devices. But it's a risk... And that leads to another question- the talk about UDI focuses on companies that need to transition into the UDI, but what about companies that are still in design & development stages? that haven't determined their product labels yet? in the lack of any definitive rules, should companies adopt the UDI rule in advance or wait it out? the downside being of course that they'll have to update their labels in the future, which may involve quite a lot a time, and logistics... What are your thoughts? Marked as spam
|
|
Private answer
Rob Packard
I would take the approach you are taking Ady. However, the FDA does not provide a lot of guidance on how labelers must segregate various versions of devices by DI code. Therefore, it's possible we may find that European's provide more guidance in this area that could result in the need to assign additional DI codes to your products. In addition, it may take the EU a 2-3 years to finalize their guidance on these requirements.
Marked as spam
|
|
|